AUA 2013 - Podcast: Intralesional therapy with collagenase clostridium histolyticum (CCH), a promising, non-surgical, minimally-invasive option for the treatment of Peyronie's disease

SAN DIEGO, CA USA ( - In this podcast, Dr. Wayne J. G. Hellstrom from Tulane University School of Medicine in New Orleans gives a summary of some of the key points and discusses results from the Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies (IMPRESS) I and II phase three trials.

In the trials, men received injectable treatments of collagenase clostridium histolyticum (CCH), an enzyme that breaks down fibrous scar tissue. Results and findings from the trials indicated participants showed improvement in both penile curvature deformity and Peyronie’s disease symptom bother.



hellstrom 02 thumb

hellstrom 03 thumb

hellstrom 13 thumb


Click HERE to view the slide presentation from Dr. Hellstrom's session

Click HERE to view the poster from Dr. Hellstrom's session


 Interview conducted at the American Urological Association (AUA) Annual Meeting - May 4 - 8, 2013 - San Diego Convention Center - San Diego, California USA

# # #

HellstromWayne John G. Hellstrom, MD, FACS, is Professor of Urology at Tulane University School of Medicine in New Orleans, Louisiana. He is Chief of the Section of Male Infertility and Sexual Dysfunction at Tulane University Health Sciences Center and Chief of the Section of Urology at Charity Hospital of New Orleans. He is also on staff at the Veterans Administration Medical Center, New Orleans.

Dr. Hellstrom received his medical degree from McGill University Medical School in Montreal, Canada, and he completed an internship and residency in general surgery in the McGill University Hospital system. Additional postdoctoral training included a residency in urology at the University of California, San Francisco, and a 2-year American Urological Association (AUA) Scholar funded fellowship in andrology from the University of California, Davis.

A Fellow of the American College of Surgeons, Dr. Hellstrom has received many honors throughout his distinguished career in urologic medicine. Among his awards are the Young Andrologist Award granted by the American Society of Andrology, the Hume Award for Excellence in Urological Research, and the AUA First Prize for Clinical Research. His professional memberships include the American Urological Association, American Society of Andrology, American Fertility Society/American Society for Reproductive Medicine, Société Internationale d'Urologie, and the International Society for Sexual Medicine (ISSM). Sexual Medicine Society of North America (SMNA) and Society for Urologic Prosthesis (SUPs).



View Full AUA 2013 Coverage